Cargando…

Clinical characteristics of patients with B-cell lymphoma enrolled in clinical trials for aggressive lymphoma in Japan: Japan Clinical Oncology Group - Lymphoma Study Group study – JCOG0108A

The clinical characteristics of B-cell lymphoma (BCL) were studied through the combined analysis of six clinical trials conducted by the Japan Clinical Oncology Group - Lymphoma Study Group (JCOG-LSG) for aggressive lymphoma in the 1990s, before the introduction of rituximab. Through a central patho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kinoshita, Tomohiro, Watanabe, Takashi, Itoh, Kuniaki, Yoshimura, Kenichi, Tobinai, Kensei, Ogura, Michinori, Yamaguchi, Motoko, Kurosawa, Mitsutoshi, Imaizumi, Yoshitaka, Ota, Shuichi, Kaba, Harumi, Mukai, Kiyoshi, Nakamura, Shigeo, Ohshima, Koichi, Hotta, Tomomitsu, Tsukasaki, Kunihiro, Nagai, Hirokazu, Shimoyama, Masanori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JSLRT 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053572/ https://www.ncbi.nlm.nih.gov/pubmed/33731548 http://dx.doi.org/10.3960/jslrt.20062

Ejemplares similares

R‐High‐CHOP/CHASER/LEED with autologous stem cell transplantation in newly diagnosed mantle cell lymphoma: JCOG0406 STUDY
por: Ogura, Michinori, et al.
Publicado: (2018)

Epidemiological and clinical features of adult T‐cell leukemia–lymphoma in Japan, 2010–2011: A nationwide survey
por: Nosaka, Kisato, et al.
Publicado: (2017)

Long‐term follow‐up after R‐High CHOP/CHASER/LEED with Auto‐PBSCT in untreated mantle cell lymphoma—Final analysis of JCOG0406
por: Ogura, Michinori, et al.
Publicado: (2023)

Geriatric Research Policy: Japan Clinical Oncology Group (JCOG) policy
por: Mizutani, Tomonori, et al.
Publicado: (2019)

Chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma: opportunities and challenges
por: Makita, Shinichi, et al.
Publicado: (2019)

Prognosis of patients with adult T‐cell leukemia/lymphoma in Japan: A nationwide hospital‐based study
por: Imaizumi, Yoshitaka, et al.
Publicado: (2020)

R‐CHOP‐14 versus R‐CHOP‐14/CHASER for upfront autologous transplantation in diffuse large B‐cell lymphoma: JCOG0908 study
por: Kagami, Yoshitoyo, et al.
Publicado: (2020)

Patient-reported outcome and quality of life research policy: Japan Clinical Oncology Group (JCOG) policy
por: Ishiki, Hiroto, et al.
Publicado: (2023)

Frequency of intravascular large B-cell lymphoma in Japan: Study of the Osaka Lymphoma Study Group
por: Chihara, Takeshi, et al.
Publicado: (2011)

P1220: CHARACTERISTICS OF SECONDARY CENTRAL NERVOUS SYSTEM INVOLVEMENT IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA – A SUPPLEMENTARY ANALYSIS OF JCOG0601
por: Shimada, K., et al.
Publicado: (2022)

Epidemiology of adult T‐cell leukemia‐lymphoma in Japan: An updated analysis, 2012‐2013
por: Ito, Shigeki, et al.
Publicado: (2021)

Clinical Trials and Treatment of ATL
por: Tsukasaki, Kunihiro, et al.
Publicado: (2012)

Targeting Chemokine Receptor CCR4 in Adult T-Cell Leukemia-Lymphoma and Other T-Cell Lymphomas
por: Tobinai, Kensei, et al.
Publicado: (2012)

Safety profile of brentuximab vedotin in Japanese patients with relapsed/refractory Hodgkin lymphoma or systemic anaplastic large cell lymphoma: a post-marketing surveillance study
por: Izutsu, Koji, et al.
Publicado: (2021)

Phase I studies of darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma: a pooled analysis of two phase I studies conducted in Japan and Korea
por: Ogura, Michinori, et al.
Publicado: (2020)

A phase I/II study of 10-min dosing of bendamustine hydrochloride (rapid infusion formulation) in patients with previously untreated indolent B-cell non-Hodgkin lymphoma, mantle cell lymphoma, or relapsed/refractory diffuse large B-cell lymphoma in Japan
por: Ishizawa, Kenichi, et al.
Publicado: (2022)

A single-arm confirmatory trial of pazopanib in patients with paclitaxel-pretreated primary cutaneous angiosarcoma: Japan Clinical Oncology Group study (JCOG1605, JCOG-PCAS protocol)
por: Oashi, Kohei, et al.
Publicado: (2020)

Clinical development of anti‐CD19 chimeric antigen receptor T‐cell therapy for B‐cell non‐Hodgkin lymphoma
por: Makita, Shinichi, et al.
Publicado: (2017)

Prognostic biomarkers in patients with localized natural killer/T-cell lymphoma treated with concurrent chemoradiotherapy
por: Yamaguchi, Motoko, et al.
Publicado: (2014)

Nationwide Hospital-Based Survey of Adult T-Cell Leukemia/Lymphoma in Japan
por: Kato, Takeharu, et al.
Publicado: (2022)

Effects of first-line chemotherapy on natural killer cells in adult T-cell leukemia–lymphoma and peripheral T-cell lymphoma
por: Ogura, Michinori, et al.
Publicado: (2016)

HLA genotyping in Japanese patients with multiple myeloma receiving bortezomib: An exploratory biomarker study of JCOG1105 (JCOG1105A1)
por: Ri, Masaki, et al.
Publicado: (2021)

Prospective evaluation of Ki-67 system in histological grading of soft tissue sarcomas in the Japan Clinical Oncology Group Study JCOG0304
por: Tanaka, Kazuhiro, et al.
Publicado: (2016)

Safety and Efficacy of Brentuximab Vedotin in the Treatment of Classic Hodgkin Lymphoma
por: Makita, Shinichi, et al.
Publicado: (2020)

Multicenter phase 1/2 study of forodesine in patients with relapsed peripheral T cell lymphoma
por: Maruyama, Dai, et al.
Publicado: (2018)

Marginal prescription equivalent to the isocenter prescription in lung stereotactic body radiotherapy: preliminary study for Japan Clinical Oncology Group trial (JCOG1408)
por: Kawahara, Daisuke, et al.
Publicado: (2017)

Follicular Lymphoma: Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up
por: Dada, Reyad, et al.
Publicado: (2019)

Hodgkin's Lymphoma: Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up
por: Alhashmi, Hani, et al.
Publicado: (2019)

ACT-25 CLINICAL TRIALS BY THE JCOG BRAIN TUMOR STUDY GROUP
por: Nishikawa, Ryo
Publicado: (2019)

Promising results of an anti-CCR4 antibody, KW-0761, for relapsed Adult T-Cell Leukemia-Lymphoma (ATL)
por: Utsunomiya, Atae, et al.
Publicado: (2011)

A multicentre phase II study of vorinostat in patients with relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
por: Ogura, Michinori, et al.
Publicado: (2014)

E7777 in Japanese patients with relapsed/refractory peripheral and cutaneous T‐cell lymphoma: A phase I study
por: Ohmachi, Ken, et al.
Publicado: (2018)

A phase-II trial of dose-dense chemotherapy in patients with disseminated thymoma: report of a Japan Clinical Oncology Group trial (JCOG 9605)
por: Kunitoh, H, et al.
Publicado: (2009)

Dummy-run for standardizing plan quality of intensity-modulated radiotherapy for postoperative uterine cervical cancer: Japan Clinical Oncology Group study (JCOG1402)
por: Okamoto, Hiroyuki, et al.
Publicado: (2019)

Single response assessment of transplant-ineligible multiple myeloma: a supplementary analysis of JCOG1105 (JCOG1105S1)
por: Nakamura, Nobuhiko, et al.
Publicado: (2021)

Oral histone deacetylase inhibitor tucidinostat (HBI‐8000) in patients with relapsed or refractory adult T‐cell leukemia/lymphoma: Phase IIb results
por: Utsunomiya, Atae, et al.
Publicado: (2022)

Mantle Cell Lymphoma: Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up
por: Alzahrani, Musa, et al.
Publicado: (2019)

Marginal Zone Lymphoma: Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up
por: Kandil, Magdy, et al.
Publicado: (2019)

A Phase II Trial of Combined Treatment of Endoscopic Mucosal Resection and Chemoradiotherapy for Clinical Stage I Esophageal Carcinoma: Japan Clinical Oncology Group Study JCOG0508
por: Kurokawa, Yukinori, et al.
Publicado: (2009)

Multidrug Resistance in Cultured Human Leukemia and Lymphoma Cell Lines Detected by a Monoclonal Antibody, MRK16
por: Ishida, Yasushi, et al.
Publicado: (1989)

Cannot write session to /tmp/vufind_sessions/sess_3cqv9sjlb0jsnrdn1858j4jth4